Literature DB >> 3001

The host component of the graft-versus-host reaction. A study on the popliteal lymph node reaction in the rat.

B Rolstad.   

Abstract

I have measured the proportion of host cells in a popliteal lymph node undergoing a graft-versus-host (GVH) reaction. By using cytotoxic alloantisera with specificity for donor and host Ag-B determined antigens, it was found that about 90% of live cells suspended from the node were of host origin. The role of host T lymphocytes in this reaction was evaluated by investigating GVH-reactivity in hosts depleted of T cells (B rats). These rats differed very little from normal hosts with regard to lymph node weight increase (which was, in fact, slightly enhanced), increase in node cellularity, and donor/host contribution. The number of i.v. infused 51Cr-labelled thoracic duct lymphocytes localizing in popliteal lymph nodes undergoing a GVH-reaction was increased, but the significance of this phenomenon for the lymph node enlargement is questionable.

Entities:  

Mesh:

Year:  1976        PMID: 3001     DOI: 10.1097/00007890-197602000-00005

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  Impairment of graft versus host reactivity in pregnant mice.

Authors:  S Nicklin; W D Billington
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

2.  Behaviorally conditioned suppression of a graft-versus-host response.

Authors:  D Bovbjerg; R Ader; N Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

3.  Polyhalogenated dibenzo-p-dioxins and dibenzofurans and the immune system. 3. No immunosuppressive effect of 2,3,7,8-TCDD in the popliteal lymph node assay (PLNA) in rats.

Authors:  M Korte; R Stahlmann; M Kubicka-Muranyi; E Gleichmann; D Neubert
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

4.  Murine cortical brain cells are autoantigenic from a distinct developmental stage onwards.

Authors:  H C Bauer; U Hurtenbach
Journal:  J Neuroimmunol       Date:  1986-07       Impact factor: 3.478

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.